DUBLIN, Oct. 5, 2023 /PRNewswire/ — Responding to the recent focus on biomedicine by China’s State Council, which seeks to “improve the business environment for foreign investment”, a timely report titled “Chinese Biopharma, Clinical Development, CRO Utilization and Outlook 2023” has…